Gemini Therapeutics

+$0.03 (+2.46%) As of 3:59 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GMTX and other ETFs, options, and stocks.

About GMTX

Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration.

CEO
Georges Gemayel
Employees
33
Headquarters
Cambridge, Massachusetts
Founded
2015

GMTX Key Statistics

Market cap
54.03M
Price-Earnings ratio
—
Dividend yield
—
Average volume
134.70K
High today
$1.29
Low today
$1.22
Open price
$1.22
Volume
18.36K
52 Week high
$12.95
52 Week low
$1.16

GMTX Earnings

-$1.18
-$0.79
-$0.39
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure